JPMorgan Funds - Thematics - Genetic Therapies C2 (acc) - EUR (hedged)

WKN A2PR3V | ISIN LU2053353152 |  Fonds
Factsheet
03.04.25
79,60 EUR-0,56 % (-0,45)

Fonds

ISIN Name Performance Volatilität Sharpe Ratio
1 BE0170813936 KBC Equity Fund Medical Technologies Classic +6,99 % +11,29 % 0,41
2 LU2036818289 CPR Invest - MedTech - H USD - Acc +4,11 % +12,42 % 0,14
3 LU2194372939 Bellevue Funds (Lux) - Bellevue Medtech & Services U2 USD - Accumulating +3,27 % +12,69 % 0,07
4 LU2384387564 CPR Invest - MedTech - A HUF - Acc +2,33 % +14,72 % -0,00
5 LU2194372855 Bellevue Funds (Lux) - Bellevue Medtech & Services U USD - Accumulating +2,97 % +12,69 % 0,05
431 LU2053353152 JPMorgan Funds - Thematics - Genetic Therapies C2 (acc) - EUR (hedged) -20,34 % +21,37 % -1,06
448 LU1864482945 Candriam Equities L Oncology, R - Capitalisation -12,75 % +11,76 % -1,28
449 LU2053353582 JPMorgan Funds - Thematics - Genetic Therapies C2 (acc) - CHF (hedged) -22,13 % +21,31 % -1,15
450 LU2098775385 JPMorgan Funds - Thematics - Genetic Therapies C (acc) - CHF (hedged) -22,20 % +21,31 % -1,15
451 LU2053353400 JPMorgan Funds - Thematics - Genetic Therapies A (acc) - CHF (hedged) -22,55 % +21,31 % -1,17
452 LU2444844174 Allianz Sustainable Health Evolution - WT6 - GBP -12,57 % +12,83 % -1,16